View clinical trials related to Skin.
Filter by:The rate of elderly population is increasing in the world. It is reported that the proportion of the world population over the age of 60 will increase to 22% by 2050 (Lichterfeld Kottner et al. 2020). With advancing age, the skin is inevitably affected and becomes more vulnerable to possible damage (Brooks et al. 2017). Additionally, as the skin ages, it undergoes many internal and external deteriorations. Intrinsic aging refers to biological changes that cannot be prevented to a large extent. External factors; exposure to conditions such as ultraviolet rays and radiation (Cowdell, 2011). In addition, in elderly individuals, conditions such as frequent washing, especially washing with harsh products, lack of hygiene, trauma, decreased peripheral satisfaction, immobility, incontinence, diabetes, vascular changes, malnutrition, use of multiple medications, depression, and dementia are among the situations that increase the risk of deterioration in skin health (Cowdell et al. 2015) Hypotheses of the Research H0-1=The care given to elderly patients according to the protocol prepared has no effect on the moisture status of the skin. H1-1= The care given to elderly patients according to the prepared protocol affects the moisture status of the skin. H0-2== The care given to elderly patients with the prepared protocol has no effect on their dermatological lives. H1-2== The care given to elderly patients with the prepared protocol has an impact on their dermatological lives. H0-3= The care provided with the protocol prepared for elderly patients has no effect on general comfort. H1-3= The care provided with the protocol prepared in elderly patients has an effect on general comfort.
This is a longitudinal, observational, direct to participant registry to better understand biological, clinical, and environmental aspects of skin/hair health and beauty.
The aim of this study is to evaluate the contribution of hydrolized collagen products to elasticity, hydration and roughness of the skin of female volunteers. Safety and tolerability of the product is the other objective of this placebo-controlled, randomized study.
Evaluation of changes in skin metabolism after one month of intake of Acqua Rocchetta (water A) vs bicarbonate-calcic mediomineral water (water B) (reprogramming effect on skin metabolism); Evaluation of urinary profiles after intake of Acqua Rocchetta (water A) vs bicarbonate-calcic mediomineral water (water B) and possible relation with skin metabolites.
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
The purpose of this study is to observe whether the transplantation of autologous stromal vascular fraction (SVF) in adipose tissue is safe and its effect on improving skin regeneration.